# Phimume® Percutaneous Left Ventricular Assist System Study

Study · id `cardio:ct-nct06639321` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06639321](<https://clinicaltrials.gov/study/NCT06639321>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT06639321

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 250 participants.

## Technical summary

Registry record NCT06639321. Randomized; no masking; primary purpose supportive care. Start 2024-10-14 (anticipated); primary completion 2025-11-14 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose supportive care
- Phase: Not applicable
- Enrolled: 250 participants (planned count; ClinicalTrials.gov record NCT06639321, source copy `cardio:ctgov-nct06639321-2024-10-15`, retrieved 2026-11-18)
- Planned start: 2024-10-14 (anticipated) (ClinicalTrials.gov record NCT06639321, source copy `cardio:ctgov-nct06639321-2024-10-15`, retrieved 2026-11-18)
- Primary completion: 2025-11-14 (anticipated) (ClinicalTrials.gov record NCT06639321, source copy `cardio:ctgov-nct06639321-2024-10-15`, retrieved 2026-11-18)
- Completion: 2026-10-14 (anticipated) (ClinicalTrials.gov record NCT06639321, source copy `cardio:ctgov-nct06639321-2024-10-15`, retrieved 2026-11-18)
- Countries: China (ClinicalTrials.gov record NCT06639321, source copy `cardio:ctgov-nct06639321-2024-10-15`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06639321-2024-10-15`, retrieved 2026-11-18)

## The registry's words

- Brief title: Phimume® Percutaneous Left Ventricular Assist System Study
- Condition: Coronary Artery Disease
- Intervention (Device): Percutaneous Ventricular Assist System
- Intervention (Device): extracorporeal membrane oxygenation (ECMO)
- Lead sponsor: Shanghai NewMed Medical Co., Ltd.
- Lead sponsor class: INDUSTRY
- Collaborator: Shanghai Phigine Medical Technology Co., Ltd.
- Collaborator class: UNKNOWN

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry lists this organization as the lead sponsor: Shanghai NewMed Medical Co., Ltd. (`cardio:org-shanghai-newmed-medical-co-ltd`)

## Provenance

Content hash: 69c479fec986d049d69dc77666f6ca4e565c4348ec29bc92af677d1ed5516257
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
